Our Partner Foundations
Every pledge is split equally between two cancer foundations — one in California, one in Sydney — honouring both of Paul's parents.
One for my mum.
One for my dad.
My mum's nominated charity was the Leukaemia Foundation in Australia, in honour of her battle with blood cancer.
My dad didn't have a nominated charity, but after facing several forms of cancer later in life, I chose City of Hope in his honour. Having lived in California for 16 years, supporting a leading cancer centre here felt like a meaningful way to recognise his journey while also honouring the place I've called home for so long.
— PAUL
“I'm walking 2,650 miles because I couldn't save them. But maybe I can help save someone else's mum or dad.”— Paul Barry, YesChapter
What your pledge helps fund
Paul chose these foundations personally — one for each parent. Every pledge is divided equally, so both are honoured with every mile he walks.
Leukaemia Foundation
Supporting Australians living with blood cancer through patient support, research funding, and advocacy — with a vision of zero lives lost to blood cancer by 2035.
Visit Leukaemia FoundationCity of Hope
A leading California cancer centre advancing breakthrough research, compassionate treatment, and clinical trials for patients and families facing cancer.
Visit City of HopeLeukaemia Foundation
Honouring Paul's mumSupporting Australians living with blood cancer through patient support, research funding, and advocacy — with a vision of zero lives lost to blood cancer by 2035.
About
The Leukaemia Foundation is Australia's only national charity dedicated exclusively to blood cancers, founded in 1975 and now operating across all states. They serve the ~150,000 Australians currently living with blood cancer — 18 of whom die every day — through patient support services, research funding, and national advocacy.
Key Programs
- Patient Support — Free accommodation for regional/rural patients travelling for treatment (700+ families/year) and transport services covering 1M+ km/year, plus counselling and financial assistance
- Research Funding — $61M+ committed to blood cancer research since 2000, funding clinical trials and laboratory research across Australia
- Advocacy — Developed Australia's National Strategic Action Plan for Blood Cancer; campaigns for equitable treatment access across all states
"18 Australians die from blood cancer every single day. The Leukaemia Foundation exists so that one day, not one more family has to go through what Paul's did."
— Leukaemia Foundation, Annual Report
City of Hope
Honouring Paul's dadA leading California cancer centre advancing breakthrough research, compassionate treatment, and clinical trials for patients and families facing cancer.
About
Founded in 1913, City of Hope is one of the largest cancer research and treatment organisations in the United States, located in Duarte, California. As one of only 57 NCI-designated comprehensive cancer centres, they combine world-class research with compassionate patient care — treating ~134,000 patients annually across their national network.
Key Programs
- Breakthrough Research — Developed synthetic human insulin and the foundational monoclonal antibody technology behind blockbuster cancer drugs Herceptin, Rituxan, and Avastin
- Cancer Treatment — World-class care for blood cancers, solid tumors, and rare cancers; 13,000+ stem cell transplants performed with outcomes exceeding national averages
- Clinical Trials — Hundreds of blood cancer trials yearly; first centre to offer CAR T-cell therapy targeting acute myeloid leukemia
"City of Hope is not just a hospital. It's a place where the science of cancer meets the humanity of healing — where researchers and doctors work side-by-side to turn today's discoveries into tomorrow's cures."
— City of Hope, Mission Statement
Science that changed cancer care
Both foundations have produced treatments now used by millions of patients worldwide.
Synthetic Human Insulin
City of Hope scientists were the first to synthesise human insulin using recombinant DNA — a breakthrough that transformed diabetes and cancer metabolic research globally.
Herceptin, Rituxan & Avastin
Foundational monoclonal antibody research led directly to three of the world's most widely used cancer drugs — now treating millions of patients annually worldwide.
National Blood Cancer Plan
Developed Australia's first National Strategic Action Plan for Blood Cancer — securing government commitment to equitable treatment access across all states and territories.
First CAR T-Cell for AML
City of Hope became the first centre to offer CAR T-cell immunotherapy targeting acute myeloid leukemia — a disease with historically poor prognosis now entering a new era.
Every pledge goes directly to these foundations.
Paul takes nothing from pledges. 100% goes to the Leukaemia Foundation and City of Hope, split equally.